DDT 10 - Chemotherapy drugs (mode of action) II Flashcards

1
Q

alternative to chlormethine

A

chloroambucil
melphalan
estramustine
uracil mustard

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

describe chloroambucil and name their properties

A

Aromatic ring is electron withdrawing
Lowers nucleophilic strength of nitrogen
Less reactive alkylating agent
Less side reactions and less toxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

describe properties of mephalan

A

Aromatic ring is present
Less reactive alkylating agent
Mimics amino acid phenylalanine
Transported into cells by transport proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

urethran

A

more hydrophic can pass through membrane through passive diffusion
steroid is hydrophobic
urethrane group is draws electrons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

uracil ring

A

Uracil ring is electron withdrawing
Less reactive alkylating agent
Mimics a nucleic acid base
Concentrated in fast growing cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

effect of DNA Alkylation

A

Alkylated guanine prefers enol tautomer
Alkylated guanine is hydrogen bond
donor / acceptor / donor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

pro drug alkylating anti-cancer

A

pro drug - have to be activated
e.g Cyclophosphamide oxidised by cytochrome P450 enzyme
nitrosoureas - desompose in the body to form activating agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how does busulfan a DNA alkylating agent - cause interstrand crosslinking

A

SN2 reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe the mechanism of the interstrand cross linking of busulfan

A

electron from nitrogen in guanine base pair moves to C in busulfan
with the help of Mesylate (MeSO3 - a good leaving group) electron from Nitrogen in the Cytosine in the other end of the DNA strand to C then electron from C busulfan moves to O in busulfan
mesylate helps form the cross link

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

mitomycin C

A

Prodrug activated in the body to form an alkylating agent
One of the most toxic anticancer drugs in clinical use
Mode of action is via DNA alkylation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

where does CC1065 bind to and is it more or less active than cisplatin

A

Naturally occurring agent
Binds to minor groove of DNA
Alkylates adenine bases
1000 times more active than cisplatin in vitro

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

oestrogen antagonist

A

Agents that antagonise the action of oestrogens are of interest
for the treatment of oestrogen dependent breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

example of oestrogen antagonist

A

tamoxifen -used to treat estrogen hormone dependant breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

17-Beta Estradiol

A

17β-Estradiol is a steroid hormone

that promotes the growth of certain tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how does tamoxifen treat hormone dependent breast cancer

A

binds to the estrogen receptor binding site without fully activating the receptor and prevents 17β-estradiol from binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

antimetabolites

A

are compounds that prevent the biosynthesis of normal cell metabolites

17
Q

example of antimetabolites

A

5-Fluorouracil (5-FU)

18
Q

principle of anti metabolites

A

Structurally designed compound based on the experimental observation that some tumour cells preferentially use uracil for the synthesis of the DNA base thymidine using a biosynthetic pathway not used by normal cells

19
Q

monoclonal antibodies

A

produced for several tumour
associated antigens and can act to activate the body’s immune
response to direct killer cells against the tumour.

20
Q

why are able to use monoclonal antibodies

A

Cancer cells have altered plasma membranes that contain
distinctive antigens which are over expressed
when compared to normal cells.

21
Q

what type of cancer does monoclonal antibodies treat/

A

breast cancers
colorectal cancers
lymphomas

22
Q

example of monoclonal antibody

A

herceptin

rituximab

23
Q

what does herceptin target and why

A

which targets the HER-2 growth factor receptor which is over expresses on 25% of breast cancers.

24
Q

what type of cancer does herceptin treat?

A

treatment of HER-2 positive metastatic breast cancer in combination with the mitotic inhibitor paclitaxel (targets tubulin)

25
Q

rituximab is against what protein?

A

CD20 found on the surface of immune system B cells

26
Q

rituximab is used to treat what kind of cancers

A

used to treat diseases which are characterized by excessive numbers of B cells or dysfunctional B cells
This includes many lymphomas and leukaemias

27
Q

Combination therapy - R-CHOP

A

one of the more widely used combination chemotherapy regimens.

28
Q

R-CHOP used for what type of cancer?

A

approved R-CHOP as a first line treatment
for non-Hodgkin’s lymphoma (NHL), B-cell NHL subtypes, including follicular lymphoma,
mantle cell lymphoma, Burkitt’s lymphoma

29
Q

what does a course of R-CHOP look like?

A

R-CHOP involves 6 to 8 treatments separated by 21 days with

30
Q

examples of alkylating anti-cancer drugs of chlormethine analogues

A

chlorambucil
melphalan
urethane
uracil mustard

31
Q

list pro-drug alkylating anti-cancer

A
cyclophosphamide
nitrosoureas: lomustine and carmustine
busulfan
mitomycin C
CC1065
Tamoxifen
32
Q

name 2 Monoclonal antibodies

A

Herceptin used w/ Paclitaxel

Rituximab